📍 ENTRY: $81.60
🛑 **STOP LOSS:** $73.00 (Risk: $8.60)
🎯 **TAKE PROFIT:** $104.50 (Reward: $22.90)
📊 R:R RATIO: ~1:2.66
🔍 TECHNICAL ANALYSIS (The Setup):
CNS just hit a new 52-week high of $81.17 on July 16, 2026. The stock has been on a powerful run, up +21.60% over the last 3 months and +29.13% year-to-date.
The 52-week range is $58.39 – $81.17 — the stock is now trading at the upper end of its range, attempting a clean breakout into blue sky territory.
Key support: The 50-day MA sits at ~$74.52** and the **200-day MA at ~$68.65. My stop loss at $73.00 is placed below the 50-day MA and just above the 200-day MA, giving the trade room to breathe while protecting against a breakdown.
Key resistance: The $81.17** 52-week high is the immediate hurdle. A confirmed breakout above this level with volume would open the door to **$90+ and beyond.
Target at $104.50: This represents a measured move projection from the base formed over the past year and approaches the upper end of long-term historical levels.
📊 FUNDAMENTAL ANALYSIS (The Catalyst – Just Released!):
Cohen & Steers reported Q2 2026 earnings on July 16 and the results were exceptional:
✅ **AUM reached a record $100.1 billion** at quarter end, up from $93.1B in Q1 2026
✅ $1.3 billion in net inflows** — the **strongest quarter since Q4 2021**
✅ **Fourth consecutive quarter of organic growth** — the longest streak since 2022
✅ **Diluted EPS of $0.95 (GAAP) and $0.85 as adjusted**
✅ **Revenue of $151.8M (adjusted), beating the $146.05M consensus by $5.8M
✅ Operating margin expanded to 34.6%, up from 31.8% a year ago
✅ Active ETFs surpassed $1 billion in AUM with six ETFs in the market
CEO Joseph Harvey commented: "We are beginning to see the benefits of improving market conditions for our investment strategies and the investments we've made in the business to expand our capabilities."
2026 Outlook (from Q1 call guidance):
Compensation ratio expected to remain at 40%
G&A expected to increase in mid-single digits year-over-year
As-adjusted effective tax rate expected to stay at 25.5%
Analyst sentiment (mixed but with upside):
Firm Rating Price Target
Evercore ISI Outperform **$84** (raised from $82)
eToro consensus Moderate Buy $84
Consensus (S&P Global) Hold $71.33
🎯 TRADE STRATEGY:
Entry at $81.60:** Entering just above the **52-week high of $81.17, anticipating a confirmed breakout with momentum as the market digests the strong Q2 earnings.
SL at $73.00:** Placed safely **below the 50-day MA (~$74.52) and above the 200-day MA (~$68.65). If price loses this level, the bullish breakout thesis is invalidated.
TP at $104.50: A measured move projection from the base formed over the past year, representing a ~28% upside from entry.
⚠️ RISK MANAGEMENT:
Earnings volatility: The stock is up +21.6% over the last 3 months. A "sell the news" reaction could still occur despite the strong results.
Valuation concerns: CNS trades at a P/E of ~26.8x, which is elevated relative to traditional asset managers. The GF Value™ is ~$79.23, suggesting the stock is fairly valued to slightly overvalued at current levels.
Mixed analyst sentiment: The S&P Global consensus is "Hold" with a $71.33 price target, implying potential downside. However, Evercore maintains an Outperform rating with an $84 target.
Insider selling: Recent insider transactions show sales by executives, which could be a cautionary signal.
Dividend payout: The quarterly dividend of $0.67 per share yields ~3.3%, but the payout ratio is elevated.
💬 What are your thoughts? Is anyone else watching this 52-week high breakout, or do you expect a pullback before the next leg up?
⚠️ DISCLAIMER:
This is NOT financial or investment advice. This post reflects my personal opinion and analysis based on publicly available information. Trading and investing involve substantial risk, including the potential loss of your entire capital. Past performance does not guarantee future results. Always do your own research (DYOR) and consult with a licensed financial advisor before making any trading decisions. I am not responsible for any losses incurred.
#CNS #CohenSteers #Earnings #Breakout #52WeekHigh #TradingSetup #TechnicalAnalysis #Stocks #AssetManagement
🛑 **STOP LOSS:** $73.00 (Risk: $8.60)
🎯 **TAKE PROFIT:** $104.50 (Reward: $22.90)
📊 R:R RATIO: ~1:2.66
🔍 TECHNICAL ANALYSIS (The Setup):
CNS just hit a new 52-week high of $81.17 on July 16, 2026. The stock has been on a powerful run, up +21.60% over the last 3 months and +29.13% year-to-date.
The 52-week range is $58.39 – $81.17 — the stock is now trading at the upper end of its range, attempting a clean breakout into blue sky territory.
Key support: The 50-day MA sits at ~$74.52** and the **200-day MA at ~$68.65. My stop loss at $73.00 is placed below the 50-day MA and just above the 200-day MA, giving the trade room to breathe while protecting against a breakdown.
Key resistance: The $81.17** 52-week high is the immediate hurdle. A confirmed breakout above this level with volume would open the door to **$90+ and beyond.
Target at $104.50: This represents a measured move projection from the base formed over the past year and approaches the upper end of long-term historical levels.
📊 FUNDAMENTAL ANALYSIS (The Catalyst – Just Released!):
Cohen & Steers reported Q2 2026 earnings on July 16 and the results were exceptional:
✅ **AUM reached a record $100.1 billion** at quarter end, up from $93.1B in Q1 2026
✅ $1.3 billion in net inflows** — the **strongest quarter since Q4 2021**
✅ **Fourth consecutive quarter of organic growth** — the longest streak since 2022
✅ **Diluted EPS of $0.95 (GAAP) and $0.85 as adjusted**
✅ **Revenue of $151.8M (adjusted), beating the $146.05M consensus by $5.8M
✅ Operating margin expanded to 34.6%, up from 31.8% a year ago
✅ Active ETFs surpassed $1 billion in AUM with six ETFs in the market
CEO Joseph Harvey commented: "We are beginning to see the benefits of improving market conditions for our investment strategies and the investments we've made in the business to expand our capabilities."
2026 Outlook (from Q1 call guidance):
Compensation ratio expected to remain at 40%
G&A expected to increase in mid-single digits year-over-year
As-adjusted effective tax rate expected to stay at 25.5%
Analyst sentiment (mixed but with upside):
Firm Rating Price Target
Evercore ISI Outperform **$84** (raised from $82)
eToro consensus Moderate Buy $84
Consensus (S&P Global) Hold $71.33
🎯 TRADE STRATEGY:
Entry at $81.60:** Entering just above the **52-week high of $81.17, anticipating a confirmed breakout with momentum as the market digests the strong Q2 earnings.
SL at $73.00:** Placed safely **below the 50-day MA (~$74.52) and above the 200-day MA (~$68.65). If price loses this level, the bullish breakout thesis is invalidated.
TP at $104.50: A measured move projection from the base formed over the past year, representing a ~28% upside from entry.
⚠️ RISK MANAGEMENT:
Earnings volatility: The stock is up +21.6% over the last 3 months. A "sell the news" reaction could still occur despite the strong results.
Valuation concerns: CNS trades at a P/E of ~26.8x, which is elevated relative to traditional asset managers. The GF Value™ is ~$79.23, suggesting the stock is fairly valued to slightly overvalued at current levels.
Mixed analyst sentiment: The S&P Global consensus is "Hold" with a $71.33 price target, implying potential downside. However, Evercore maintains an Outperform rating with an $84 target.
Insider selling: Recent insider transactions show sales by executives, which could be a cautionary signal.
Dividend payout: The quarterly dividend of $0.67 per share yields ~3.3%, but the payout ratio is elevated.
💬 What are your thoughts? Is anyone else watching this 52-week high breakout, or do you expect a pullback before the next leg up?
⚠️ DISCLAIMER:
This is NOT financial or investment advice. This post reflects my personal opinion and analysis based on publicly available information. Trading and investing involve substantial risk, including the potential loss of your entire capital. Past performance does not guarantee future results. Always do your own research (DYOR) and consult with a licensed financial advisor before making any trading decisions. I am not responsible for any losses incurred.
#CNS #CohenSteers #Earnings #Breakout #52WeekHigh #TradingSetup #TechnicalAnalysis #Stocks #AssetManagement
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.